196 related articles for article (PubMed ID: 26924474)
1. PTH signaling mediates perilacunar remodeling during exercise.
Gardinier JD; Al-Omaishi S; Morris MD; Kohn DH
Matrix Biol; 2016; 52-54():162-175. PubMed ID: 26924474
[TBL] [Abstract][Full Text] [Related]
2. Examining the influence of PTH(1-34) on tissue strength and composition.
Gardinier JD; Al-Omaishi S; Rostami N; Morris MD; Kohn DH
Bone; 2018 Dec; 117():130-137. PubMed ID: 30261327
[TBL] [Abstract][Full Text] [Related]
3. Sequential Treatment of Estrogen Deficient, Osteopenic Rats with Alendronate, Parathyroid Hormone (1-34), or Raloxifene Alters Cortical Bone Mineral and Matrix Composition.
Taylor EA; Donnelly E; Yao X; Johnson ML; Amugongo SK; Kimmel DB; Lane NE
Calcif Tissue Int; 2020 Mar; 106(3):303-314. PubMed ID: 31784772
[TBL] [Abstract][Full Text] [Related]
4. Osteocytic perilacunar/canalicular turnover in hemodialysis patients with high and low serum PTH levels.
Yajima A; Tsuchiya K; Burr DB; Minner DE; Condon KW; Miller CA; Satoh S; Inaba M; Nakayama T; Tanizawa T; Ito A; Nitta K
Bone; 2018 Aug; 113():68-76. PubMed ID: 29738853
[TBL] [Abstract][Full Text] [Related]
5. PTH Signaling During Exercise Contributes to Bone Adaptation.
Gardinier JD; Mohamed F; Kohn DH
J Bone Miner Res; 2015 Jun; 30(6):1053-63. PubMed ID: 25529455
[TBL] [Abstract][Full Text] [Related]
6. The Contribution of Perilacunar Composition and Mechanical Properties to Whole-Bone Mechanical Outcomes in Streptozotocin-Induced Diabetes.
Bolger MW; Tekkey T; Kohn DH
Calcif Tissue Int; 2023 Aug; 113(2):229-245. PubMed ID: 37261462
[TBL] [Abstract][Full Text] [Related]
7. Effect of osteoporosis treatment agents on the cortical bone osteocyte microenvironment in adult estrogen-deficient, osteopenic rats.
Stern AR; Yao X; Wang Y; Berhe A; Dallas M; Johnson ML; Yao W; Kimmel DB; Lane NE
Bone Rep; 2018 Jun; 8():115-124. PubMed ID: 29955630
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of Gα11 in Osteoblast Lineage Cells Suppresses the Osteoanabolic Response to Intermittent PTH and Exercise.
Dela Cruz A; Grynpas MD; Mitchell J
Calcif Tissue Int; 2016 Oct; 99(4):423-34. PubMed ID: 27300035
[TBL] [Abstract][Full Text] [Related]
9. Parathyroid Hormone Signaling in Osteocytes.
Wein MN
JBMR Plus; 2018 Jan; 2(1):22-30. PubMed ID: 30283888
[TBL] [Abstract][Full Text] [Related]
10. Glucocorticoid suppression of osteocyte perilacunar remodeling is associated with subchondral bone degeneration in osteonecrosis.
Fowler TW; Acevedo C; Mazur CM; Hall-Glenn F; Fields AJ; Bale HA; Ritchie RO; Lotz JC; Vail TP; Alliston T
Sci Rep; 2017 Mar; 7():44618. PubMed ID: 28327602
[TBL] [Abstract][Full Text] [Related]
11. YAP and TAZ Mediate Osteocyte Perilacunar/Canalicular Remodeling.
Kegelman CD; Coulombe JC; Jordan KM; Horan DJ; Qin L; Robling AG; Ferguson VL; Bellido TM; Boerckel JD
J Bone Miner Res; 2020 Jan; 35(1):196-210. PubMed ID: 31610061
[TBL] [Abstract][Full Text] [Related]
12. Calcimimetics Alter Periosteal and Perilacunar Bone Matrix Composition and Material Properties in Early Chronic Kidney Disease.
Damrath JG; Moe SM; Wallace JM
J Bone Miner Res; 2022 Jul; 37(7):1297-1306. PubMed ID: 35593150
[TBL] [Abstract][Full Text] [Related]
13. Cathepsin K-deficient osteocytes prevent lactation-induced bone loss and parathyroid hormone suppression.
Lotinun S; Ishihara Y; Nagano K; Kiviranta R; Carpentier VT; Neff L; Parkman V; Ide N; Hu D; Dann P; Brooks D; Bouxsein ML; Wysolmerski J; Gori F; Baron R
J Clin Invest; 2019 May; 129(8):3058-3071. PubMed ID: 31112135
[TBL] [Abstract][Full Text] [Related]
14. Tissue strain amplification at the osteocyte lacuna: a microstructural finite element analysis.
Bonivtch AR; Bonewald LF; Nicolella DP
J Biomech; 2007; 40(10):2199-206. PubMed ID: 17196968
[TBL] [Abstract][Full Text] [Related]
15. Parathyroid hormone attenuates radiation-induced increases in collagen crosslink ratio at periosteal surfaces of mouse tibia.
Oest ME; Gong B; Esmonde-White K; Mann KA; Zimmerman ND; Damron TA; Morris MD
Bone; 2016 May; 86():91-97. PubMed ID: 26960578
[TBL] [Abstract][Full Text] [Related]
16. Anabolic action of parathyroid hormone (PTH) does not compromise bone matrix mineral composition or maturation.
Vrahnas C; Pearson TA; Brunt AR; Forwood MR; Bambery KR; Tobin MJ; Martin TJ; Sims NA
Bone; 2016 Dec; 93():146-154. PubMed ID: 27686599
[TBL] [Abstract][Full Text] [Related]
17. Lipoprotein receptor-related protein 6 is required for parathyroid hormone-induced Sost suppression.
Li C; Wang W; Xie L; Luo X; Cao X; Wan M
Ann N Y Acad Sci; 2016 Jan; 1364(1):62-73. PubMed ID: 25847683
[TBL] [Abstract][Full Text] [Related]
18. Osteocyte-Intrinsic TGF-β Signaling Regulates Bone Quality through Perilacunar/Canalicular Remodeling.
Dole NS; Mazur CM; Acevedo C; Lopez JP; Monteiro DA; Fowler TW; Gludovatz B; Walsh F; Regan JN; Messina S; Evans DS; Lang TF; Zhang B; Ritchie RO; Mohammad KS; Alliston T
Cell Rep; 2017 Nov; 21(9):2585-2596. PubMed ID: 29186693
[TBL] [Abstract][Full Text] [Related]
19. The skeleton in primary hyperparathyroidism: a review focusing on bone remodeling, structure, mass, and fracture.
Christiansen P
APMIS Suppl; 2001; (102):1-52. PubMed ID: 11419022
[TBL] [Abstract][Full Text] [Related]
20. Osteocytes' expression of the PTH/PTHrP receptor has differing effects on endocortical and periosteal bone formation during adenine-induced CKD.
Gardinier JD; Daly-Seiler CS; Zhang C
Bone; 2020 Apr; 133():115186. PubMed ID: 31987988
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
